DUCTAL CARCINOMA IN SITU
Clinical trials for DUCTAL CARCINOMA IN SITU explained in plain language.
Never miss a new study
Get alerted when new DUCTAL CARCINOMA IN SITU trials appear
Sign up with your email to follow new studies for DUCTAL CARCINOMA IN SITU, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New scanner aims to cut repeat breast cancer surgeries
Disease control Recruiting nowThis trial tests a new device called the EndoSCell Scanner, which uses fluorescence imaging to help surgeons see if any cancer cells remain after removing a breast tumor. About 172 women with breast cancer will have their surgical cavity scanned during surgery. If the scanner det…
Matched conditions: DUCTAL CARCINOMA IN SITU
Phase: NA • Sponsor: Guangdong Provincial People's Hospital • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Could Once-Daily radiation replace Twice-Daily for breast cancer recurrence?
Disease control Recruiting nowThis study is for women whose breast cancer has come back after initial breast-conserving surgery and whole breast radiation. The standard treatment after repeat surgery is radiation twice a day for 30 sessions. This trial tests whether giving radiation once a day for 15 sessions…
Matched conditions: DUCTAL CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New dye could spare thousands of women from unnecessary lymph node removal
Disease control Recruiting nowThis study tests a new dye called Magtrace that stays in the lymph nodes for weeks. For women with non-invasive breast cancer (DCIS) having a mastectomy, this dye may allow doctors to safely delay lymph node removal until after the breast tissue is checked for hidden invasive can…
Matched conditions: DUCTAL CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Could hormone pills replace surgery for some early breast cancers?
Disease control Recruiting nowThis study tests whether active surveillance (close monitoring) combined with hormonal therapy can safely manage ductal carcinoma in situ (DCIS), a very early form of breast cancer. About 400 women with hormone-positive DCIS will receive either standard or investigational hormone…
Matched conditions: DUCTAL CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: QuantumLeap Healthcare Collaborative • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New study aims to spare healthy breast tissue during cancer surgery
Disease control Recruiting nowThis study compares two surgical approaches for breast cancer: one that removes extra tissue around the tumor (routine cavity shave margins) and one that uses a special device (Savi Scout®) to guide removal of only suspicious margins. About 204 women with early-stage breast cance…
Matched conditions: DUCTAL CARCINOMA IN SITU
Phase: NA • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
One-Week radiation shows promise for breast cancer patients
Disease control Recruiting nowThis study tests a new, ultra-short radiation schedule for early-stage breast cancer. Instead of the usual 3 weeks, patients receive 5 radiation sessions over one week, with an extra boost to the tumor site given at the same time. The goal is to see if this approach is safe, redu…
Matched conditions: DUCTAL CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Can exercise rebuild strength after breast cancer? new study investigates
Disease control Recruiting nowThis study looks at how different group exercise programs affect fitness and body composition in women who have finished breast cancer treatment. About 15 women will try one of four supervised resistance training regimens. The goal is to see which approach best improves heart-lun…
Matched conditions: DUCTAL CARCINOMA IN SITU
Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New hope for breast cancer recurrence: repeat radiation may spare the breast
Disease control Recruiting nowThis study is for women aged 51 or older whose breast cancer has returned or who have a new cancer in the same breast. The goal is to see if giving a focused, short course of radiation before surgery is safe and effective enough to allow breast-conserving treatment instead of mas…
Matched conditions: DUCTAL CARCINOMA IN SITU
Phase: NA • Sponsor: The Netherlands Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New scanner could slash repeat breast cancer surgeries
Disease control Recruiting nowThis study tests a special scanner that helps surgeons see if any cancer cells are left behind during breast-conserving surgery. The goal is to remove all cancer in one go and avoid a second operation. About 100 women with invasive or in-situ breast cancer will take part. The sca…
Matched conditions: DUCTAL CARCINOMA IN SITU
Phase: NA • Sponsor: University of Fribourg • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
One-Time radiation during lumpectomy may simplify breast cancer treatment
Disease control Recruiting nowThis registry study is following 500 women with early-stage breast cancer who receive a single dose of radiation directly to the tumor site during surgery (IORT). The goal is to see how well this approach controls cancer locally and what side effects occur. Participants are women…
Matched conditions: DUCTAL CARCINOMA IN SITU
Sponsor: Albert Einstein College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Proton beam zaps breast tumors with less damage?
Disease control Recruiting nowThis study tests proton radiation therapy for women with early-stage breast cancer. The goal is to see if targeting only the tumor area can keep cancer from coming back while causing fewer side effects. About 132 women aged 50 and older will take part. Researchers will track recu…
Matched conditions: DUCTAL CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: Proton Collaborative Group • Aim: Disease control
Last updated Jun 26, 2026 15:14 UTC
-
New scan aims to uncover hidden breast cancer in early stage patients
Diagnosis Recruiting nowThis study tests a new imaging method called FAPI-PET/MRI to see if it can detect hidden invasive breast cancer in 30 people diagnosed with ductal carcinoma in situ (DCIS), a common pre-stage of breast cancer. Participants receive a weakly radioactive drug and lie in a scanner fo…
Matched conditions: DUCTAL CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: Universität Münster • Aim: Diagnosis
Last updated Jun 27, 2026 13:01 UTC
-
New AI-Powered 'Eye' could slash repeat breast cancer surgeries
Diagnosis Recruiting nowThis study tests a new handheld device that uses light and artificial intelligence to check for leftover cancer cells right after a breast lump is removed. The goal is to help surgeons remove all cancer in one go, avoiding a second surgery. About 104 women having breast-conservin…
Matched conditions: DUCTAL CARCINOMA IN SITU
Sponsor: Istituti Clinici Scientifici Maugeri SpA • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
Could a vaccine stop breast cancer before it starts? new trial launches
Prevention Recruiting nowThis early-stage trial is testing whether a vaccine targeting the MUC1 protein, combined with hormone therapy, can help prevent ductal carcinoma in situ (DCIS) from becoming invasive breast cancer. Fifty women with ER-positive DCIS will receive either hormone therapy alone or hor…
Matched conditions: DUCTAL CARCINOMA IN SITU
Phase: PHASE1 • Sponsor: Finn, Olivera, PhD • Aim: Prevention
Last updated Jun 27, 2026 11:01 UTC
-
Exercise after breast reconstruction: a new path to faster recovery?
Symptom relief Recruiting nowThis study looks at whether a structured 12-week exercise program can improve fitness and recovery in women who have had DIEP flap breast reconstruction after mastectomy. Half of the 78 participants will follow the exercise program, while the other half will receive standard care…
Matched conditions: DUCTAL CARCINOMA IN SITU
Phase: NA • Sponsor: Royal College of Surgeons, Ireland • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Could a week of radiation be enough for breast cancer?
Symptom relief Recruiting nowThis study is testing a very short course of radiation therapy for women with early-stage breast cancer. Instead of weeks of treatment, participants receive whole breast radiation with a targeted boost over just 5 days. Researchers will track how the breast looks and feels, and h…
Matched conditions: DUCTAL CARCINOMA IN SITU
Phase: NA • Sponsor: University of Wisconsin, Madison • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Robot surgeons take on breast cancer: will they beat the scalpel?
Symptom relief Recruiting nowThis study compares two ways to perform nipple-sparing mastectomy with immediate DIEP flap breast reconstruction: robotic-assisted surgery through a single small incision, versus the standard open surgery with a larger cut. The goal is to see which approach leads to better patien…
Matched conditions: DUCTAL CARCINOMA IN SITU
Phase: NA • Sponsor: Beaumont Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Can special workouts help breast cancer survivors regain muscle?
Symptom relief Recruiting nowThis study compares two standard exercise programs to see which one better helps women increase muscle mass after breast cancer treatment. Thirty women aged 20-89 who have completed treatment (except chemotherapy) will follow either standard resistance training or a special 6-12-…
Matched conditions: DUCTAL CARCINOMA IN SITU
Phase: NA • Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
Invisible ink could replace permanent tattoos for radiation therapy
Symptom relief Recruiting nowThis study tests a special ink called Magic Ink that is only visible under UV light, used to mark the skin for daily radiation treatment in breast cancer patients. The goal is to see if it is as safe and effective as standard permanent tattoo ink, while being less noticeable. Thi…
Matched conditions: DUCTAL CARCINOMA IN SITU
Phase: NA • Sponsor: Barbara Ann Karmanos Cancer Institute • Aim: Symptom relief
Last updated Jun 26, 2026 18:07 UTC
-
New decision aid aims to ease breast reconstruction choices
Knowledge-focused Recruiting nowThis study tests whether a decision aid tool called RECONJOINT is practical for helping women choose breast reconstruction after mastectomy. About 131 women with breast cancer or a genetic risk will use the tool. The goal is to see if a larger study can be done to improve shared …
Matched conditions: DUCTAL CARCINOMA IN SITU
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Patients and doctors join forces to redesign breast cancer care
Knowledge-focused Recruiting nowThis study aims to understand the current state of breast cancer care by surveying both patients and doctors. The goal is to identify gaps in communication and time management, and to develop new, patient-focused care models. About 2000 adults with breast cancer and their physici…
Matched conditions: DUCTAL CARCINOMA IN SITU
Sponsor: University Hospital Augsburg • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Could 3D imaging during breast surgery cut down repeat operations?
Knowledge-focused Recruiting nowThis study tests whether a new 3D imaging method used during breast cancer surgery helps surgeons remove all cancer cells the first time. About 314 women having breast-conserving surgery will be randomly assigned to either standard 2D imaging or the new 3D imaging. The goal is to…
Matched conditions: DUCTAL CARCINOMA IN SITU
Phase: NA • Sponsor: Royal College of Surgeons, Ireland • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Breast cancer drugs linked to blood sugar changes? new study investigates
Knowledge-focused Recruiting nowThis study is looking at how hormone treatments for breast cancer, called aromatase inhibitors and tamoxifen, affect blood sugar control and diabetes risk in postmenopausal women. Researchers will compare blood sugar measures in women taking these drugs to healthy women not on tr…
Matched conditions: DUCTAL CARCINOMA IN SITU
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
New breast surgery technique aims to reduce scars and improve outcomes
Knowledge-focused Recruiting nowThis study reviews data from 250 women who had a special type of breast-conserving surgery for early-stage breast cancer. The surgery uses nearby skin and fat flaps to fill the area where the tumor was removed, aiming to avoid visible scars and keep the breast looking natural. Re…
Matched conditions: DUCTAL CARCINOMA IN SITU
Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
New study investigates whether social struggles fuel inflammation in breast cancer patients
Knowledge-focused Recruiting nowThis pilot study looks at how social determinants of health—like housing, food, and transportation—relate to inflammation in women newly diagnosed with breast cancer. Participants fill out surveys and give a blood sample at a single visit. The goal is to understand these connecti…
Matched conditions: DUCTAL CARCINOMA IN SITU
Sponsor: Thomas Jefferson University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
New tool aims to help breast cancer patients choose reconstruction
Knowledge-focused Recruiting nowThis study tests a decision aid called BREASTChoice in 20 breast cancer patients who had breast surgery. Participants use the tool on their phones and share their thoughts in interviews. Researchers measure how much patients learn about reconstruction options using a knowledge su…
Matched conditions: DUCTAL CARCINOMA IN SITU
Phase: NA • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
New marker could make breast cancer radiation more precise
Knowledge-focused Recruiting nowThis study tests a new way to mark the area where a breast tumor was removed, so radiation therapy can be more accurately aimed afterward. About 50 adults with early-stage breast cancer or a precancerous condition called DCIS will take part. The goal is to see if this marking hel…
Matched conditions: DUCTAL CARCINOMA IN SITU
Phase: NA • Sponsor: University of Florida • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC